Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.

Identifieur interne : 001513 ( PubMed/Curation ); précédent : 001512; suivant : 001514

The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.

Auteurs : Valerie W. Rusch [États-Unis] ; Kari Chansky [États-Unis] ; Hedy L. Kindler [États-Unis] ; Anna K. Nowak [Australie] ; Harvey I. Pass [États-Unis] ; David C. Rice [États-Unis] ; Lynn Shemanski [États-Unis] ; Françoise Galateau-Sallé [France] ; Brian C. Mccaughan [Australie] ; Takashi Nakano [Japon] ; Enrico Ruffini [Italie] ; Jan P. Van Meerbeeck [Belgique] ; Masahiro Yoshimura [Japon]

Source :

RBID : pubmed:27687962

Descripteurs français

English descriptors

Abstract

The M component and TNM stage groupings for malignant pleural mesothelioma (MPM) have been empirical. The International Association for the Study of Lung Cancer developed a multinational database to propose evidence-based revisions for the eighth edition of the TNM classification of MPM.

DOI: 10.1016/j.jtho.2016.09.124
PubMed: 27687962

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:27687962

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.</title>
<author>
<name sortKey="Rusch, Valerie W" sort="Rusch, Valerie W" uniqKey="Rusch V" first="Valerie W" last="Rusch">Valerie W. Rusch</name>
<affiliation wicri:level="2">
<nlm:affiliation>Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: ruschv@mskcc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chansky, Kari" sort="Chansky, Kari" uniqKey="Chansky K" first="Kari" last="Chansky">Kari Chansky</name>
<affiliation wicri:level="2">
<nlm:affiliation>Cancer Research And Biostatistics, Seattle, Washington.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Cancer Research And Biostatistics, Seattle</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kindler, Hedy L" sort="Kindler, Hedy L" uniqKey="Kindler H" first="Hedy L" last="Kindler">Hedy L. Kindler</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Nowak, Anna K" sort="Nowak, Anna K" uniqKey="Nowak A" first="Anna K" last="Nowak">Anna K. Nowak</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Pass, Harvey I" sort="Pass, Harvey I" uniqKey="Pass H" first="Harvey I" last="Pass">Harvey I. Pass</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Cardiothoracic Surgery, New York University Medical Center, New York, New York.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Cardiothoracic Surgery, New York University Medical Center, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Rice, David C" sort="Rice, David C" uniqKey="Rice D" first="David C" last="Rice">David C. Rice</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Thoracic and Cardiovascular Surgery, M.D. Anderson Cancer Center, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Thoracic and Cardiovascular Surgery, M.D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Shemanski, Lynn" sort="Shemanski, Lynn" uniqKey="Shemanski L" first="Lynn" last="Shemanski">Lynn Shemanski</name>
<affiliation wicri:level="2">
<nlm:affiliation>Cancer Research And Biostatistics, Seattle, Washington.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Cancer Research And Biostatistics, Seattle</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Galateau Salle, Francoise" sort="Galateau Salle, Francoise" uniqKey="Galateau Salle F" first="Françoise" last="Galateau-Sallé">Françoise Galateau-Sallé</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biopathology, Centre Leon Berard, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Biopathology, Centre Leon Berard, Lyon</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mccaughan, Brian C" sort="Mccaughan, Brian C" uniqKey="Mccaughan B" first="Brian C" last="Mccaughan">Brian C. Mccaughan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sydney Cardiothoracic Surgeons, Royal Prince Alfred Medical Centre, Sydney, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Sydney Cardiothoracic Surgeons, Royal Prince Alfred Medical Centre, Sydney, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nakano, Takashi" sort="Nakano, Takashi" uniqKey="Nakano T" first="Takashi" last="Nakano">Takashi Nakano</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ruffini, Enrico" sort="Ruffini, Enrico" uniqKey="Ruffini E" first="Enrico" last="Ruffini">Enrico Ruffini</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Surgical Sciences, City of Health and Science Hospital, University of Turin, Turin, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Surgical Sciences, City of Health and Science Hospital, University of Turin, Turin</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Van Meerbeeck, Jan P" sort="Van Meerbeeck, Jan P" uniqKey="Van Meerbeeck J" first="Jan P" last="Van Meerbeeck">Jan P. Van Meerbeeck</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Thoracic Oncology, Antwerp University Hospital, Edegem</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yoshimura, Masahiro" sort="Yoshimura, Masahiro" uniqKey="Yoshimura M" first="Masahiro" last="Yoshimura">Masahiro Yoshimura</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Thoracic Surgery, Hyogo Cancer Center, Akashi City, Hyogo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Thoracic Surgery, Hyogo Cancer Center, Akashi City, Hyogo</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27687962</idno>
<idno type="pmid">27687962</idno>
<idno type="doi">10.1016/j.jtho.2016.09.124</idno>
<idno type="wicri:Area/PubMed/Corpus">001535</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001535</idno>
<idno type="wicri:Area/PubMed/Curation">001513</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001513</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.</title>
<author>
<name sortKey="Rusch, Valerie W" sort="Rusch, Valerie W" uniqKey="Rusch V" first="Valerie W" last="Rusch">Valerie W. Rusch</name>
<affiliation wicri:level="2">
<nlm:affiliation>Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: ruschv@mskcc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chansky, Kari" sort="Chansky, Kari" uniqKey="Chansky K" first="Kari" last="Chansky">Kari Chansky</name>
<affiliation wicri:level="2">
<nlm:affiliation>Cancer Research And Biostatistics, Seattle, Washington.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Cancer Research And Biostatistics, Seattle</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kindler, Hedy L" sort="Kindler, Hedy L" uniqKey="Kindler H" first="Hedy L" last="Kindler">Hedy L. Kindler</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Nowak, Anna K" sort="Nowak, Anna K" uniqKey="Nowak A" first="Anna K" last="Nowak">Anna K. Nowak</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Pass, Harvey I" sort="Pass, Harvey I" uniqKey="Pass H" first="Harvey I" last="Pass">Harvey I. Pass</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Cardiothoracic Surgery, New York University Medical Center, New York, New York.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Cardiothoracic Surgery, New York University Medical Center, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Rice, David C" sort="Rice, David C" uniqKey="Rice D" first="David C" last="Rice">David C. Rice</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Thoracic and Cardiovascular Surgery, M.D. Anderson Cancer Center, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Thoracic and Cardiovascular Surgery, M.D. Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Shemanski, Lynn" sort="Shemanski, Lynn" uniqKey="Shemanski L" first="Lynn" last="Shemanski">Lynn Shemanski</name>
<affiliation wicri:level="2">
<nlm:affiliation>Cancer Research And Biostatistics, Seattle, Washington.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Cancer Research And Biostatistics, Seattle</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Galateau Salle, Francoise" sort="Galateau Salle, Francoise" uniqKey="Galateau Salle F" first="Françoise" last="Galateau-Sallé">Françoise Galateau-Sallé</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biopathology, Centre Leon Berard, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Biopathology, Centre Leon Berard, Lyon</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mccaughan, Brian C" sort="Mccaughan, Brian C" uniqKey="Mccaughan B" first="Brian C" last="Mccaughan">Brian C. Mccaughan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sydney Cardiothoracic Surgeons, Royal Prince Alfred Medical Centre, Sydney, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Sydney Cardiothoracic Surgeons, Royal Prince Alfred Medical Centre, Sydney, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nakano, Takashi" sort="Nakano, Takashi" uniqKey="Nakano T" first="Takashi" last="Nakano">Takashi Nakano</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ruffini, Enrico" sort="Ruffini, Enrico" uniqKey="Ruffini E" first="Enrico" last="Ruffini">Enrico Ruffini</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Surgical Sciences, City of Health and Science Hospital, University of Turin, Turin, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Surgical Sciences, City of Health and Science Hospital, University of Turin, Turin</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Van Meerbeeck, Jan P" sort="Van Meerbeeck, Jan P" uniqKey="Van Meerbeeck J" first="Jan P" last="Van Meerbeeck">Jan P. Van Meerbeeck</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Thoracic Oncology, Antwerp University Hospital, Edegem</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yoshimura, Masahiro" sort="Yoshimura, Masahiro" uniqKey="Yoshimura M" first="Masahiro" last="Yoshimura">Masahiro Yoshimura</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Thoracic Surgery, Hyogo Cancer Center, Akashi City, Hyogo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Thoracic Surgery, Hyogo Cancer Center, Akashi City, Hyogo</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</title>
<idno type="eISSN">1556-1380</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Humans</term>
<term>Lung Neoplasms (classification)</term>
<term>Lung Neoplasms (pathology)</term>
<term>Mesothelioma (classification)</term>
<term>Mesothelioma (pathology)</term>
<term>Neoplasm Staging (classification)</term>
<term>Pleural Neoplasms (classification)</term>
<term>Pleural Neoplasms (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Humains</term>
<term>Mésothéliome ()</term>
<term>Mésothéliome (anatomopathologie)</term>
<term>Stade de la tumeur ()</term>
<term>Tumeurs de la plèvre ()</term>
<term>Tumeurs de la plèvre (anatomopathologie)</term>
<term>Tumeurs du poumon ()</term>
<term>Tumeurs du poumon (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Mésothéliome</term>
<term>Tumeurs de la plèvre</term>
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en">
<term>Lung Neoplasms</term>
<term>Mesothelioma</term>
<term>Neoplasm Staging</term>
<term>Pleural Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lung Neoplasms</term>
<term>Mesothelioma</term>
<term>Pleural Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Mésothéliome</term>
<term>Stade de la tumeur</term>
<term>Tumeurs de la plèvre</term>
<term>Tumeurs du poumon</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The M component and TNM stage groupings for malignant pleural mesothelioma (MPM) have been empirical. The International Association for the Study of Lung Cancer developed a multinational database to propose evidence-based revisions for the eighth edition of the TNM classification of MPM.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27687962</PMID>
<DateCreated>
<Year>2016</Year>
<Month>09</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-1380</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2016</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</Title>
<ISOAbbreviation>J Thorac Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.</ArticleTitle>
<Pagination>
<MedlinePgn>2112-2119</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1556-0864(16)31074-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtho.2016.09.124</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The M component and TNM stage groupings for malignant pleural mesothelioma (MPM) have been empirical. The International Association for the Study of Lung Cancer developed a multinational database to propose evidence-based revisions for the eighth edition of the TNM classification of MPM.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Data from 29 centers were submitted either electronically or by transfer of existing institutional databases. The M component as it currently stands was validated by confirming sufficient discrimination (by Kaplan-Meier analysis) with respect to overall survival (OS) between the clinical M0 (cM0) and cM1 categories. Candidate stage groups were developed by using a recursive partitioning and amalgamation algorithm applied to all cM0 cases.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 3519 submitted cases, 2414 were analyzable and 84 were cM1 cases. Median OS for cM1 cases was 9.7 months versus 13.4 months (p = 0.0013) for the locally advanced (T4 or N3) cM0 cases, supporting inclusion of only cM1 in the stage IV group. Exploratory analyses suggest a possible difference in OS for single- versus multiple-site cM1 cases. A recursive partitioning and amalgamation-generated survival tree on the OS outcomes restricted to cM0 cases with the newly proposed (eighth edition) T and N components indicates that optimal stage groupings for the eighth edition will be as follows: stage IA (T1N0), stage IB (T2-3N0), stage II (T1-2N1), stage IIIA (T3N1), stage IIIB (T1-3N2 or any T4), and stage IV (any M1).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This first evidence-based revision of the TNM classification for MPM leads to substantial changes in the T and N components and the stage groupings.</AbstractText>
<CopyrightInformation>Copyright © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rusch</LastName>
<ForeName>Valerie W</ForeName>
<Initials>VW</Initials>
<AffiliationInfo>
<Affiliation>Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: ruschv@mskcc.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chansky</LastName>
<ForeName>Kari</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Cancer Research And Biostatistics, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kindler</LastName>
<ForeName>Hedy L</ForeName>
<Initials>HL</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nowak</LastName>
<ForeName>Anna K</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pass</LastName>
<ForeName>Harvey I</ForeName>
<Initials>HI</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, New York University Medical Center, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rice</LastName>
<ForeName>David C</ForeName>
<Initials>DC</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic and Cardiovascular Surgery, M.D. Anderson Cancer Center, Houston, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shemanski</LastName>
<ForeName>Lynn</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Cancer Research And Biostatistics, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Galateau-Sallé</LastName>
<ForeName>Françoise</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Biopathology, Centre Leon Berard, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McCaughan</LastName>
<ForeName>Brian C</ForeName>
<Initials>BC</Initials>
<AffiliationInfo>
<Affiliation>Sydney Cardiothoracic Surgeons, Royal Prince Alfred Medical Centre, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakano</LastName>
<ForeName>Takashi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ruffini</LastName>
<ForeName>Enrico</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Sciences, City of Health and Science Hospital, University of Turin, Turin, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Meerbeeck</LastName>
<ForeName>Jan P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yoshimura</LastName>
<ForeName>Masahiro</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery, Hyogo Cancer Center, Akashi City, Hyogo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>IASLC Staging and Prognostic Factors Committee, advisory boards, and participating institutions</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Thorac Oncol</MedlineTA>
<NlmUniqueID>101274235</NlmUniqueID>
<ISSNLinking>1556-0864</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C562839">Mesothelioma, Malignant</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008654" MajorTopicYN="N">Mesothelioma</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010997" MajorTopicYN="N">Pleural Neoplasms</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Mesothelioma</Keyword>
<Keyword MajorTopicYN="N">Staging</Keyword>
<Keyword MajorTopicYN="N">Staging system</Keyword>
<Keyword MajorTopicYN="N">TNM stage groupings</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Goldstraw</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rami-Porta</LastName>
<ForeName>Ramón</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Asamura</LastName>
<ForeName>Hisao</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ball</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Beer</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Beyruti</LastName>
<ForeName>Ricardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bolejack</LastName>
<ForeName>Vanessa</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chansky</LastName>
<ForeName>Kari</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Crowley</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Detterbeck</LastName>
<ForeName>Frank C</ForeName>
<Initials>FC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eberhardt</LastName>
<ForeName>Wilfried Ernst Erich</ForeName>
<Initials>WE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Edwards</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Galateau-Sallé</LastName>
<ForeName>Françoise</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Giroux</LastName>
<ForeName>Dorothy</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gleeson</LastName>
<ForeName>Fergus</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Groome</LastName>
<ForeName>Patti</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kennedy</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Jhingook</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Young Tae</ForeName>
<Initials>YT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kingsbury</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kondo</LastName>
<ForeName>Haruhiko</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Krasnik</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kubota</LastName>
<ForeName>Kaoru</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lerut</LastName>
<ForeName>Toni</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lyons</LastName>
<ForeName>Gustavo</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marino</LastName>
<ForeName>Mirella</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marom</LastName>
<ForeName>Edith M</ForeName>
<Initials>EM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van Meerbeeck</LastName>
<ForeName>Jan P</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mitchell</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nakano</LastName>
<ForeName>Takashi</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nicholson</LastName>
<ForeName>Andrew G</ForeName>
<Initials>AG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nowak</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peake</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rice</LastName>
<ForeName>Thomas W</ForeName>
<Initials>TW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rosenzweig</LastName>
<ForeName>Kenneth</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ruffini</LastName>
<ForeName>Enrico</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rusch</LastName>
<ForeName>Valerie W</ForeName>
<Initials>VW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saijo</LastName>
<ForeName>Nagahiro</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Van Schil</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sculier</LastName>
<ForeName>Jean-Paul</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Shemanski</LastName>
<ForeName>Lynn</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stratton</LastName>
<ForeName>Kelly</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Kenji</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tachimori</LastName>
<ForeName>Yuji</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>Charles F</ForeName>
<Initials>CF</Initials>
<Suffix>Jr</Suffix>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Travis</LastName>
<ForeName>William D</ForeName>
<Initials>WD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tsao</LastName>
<ForeName>Ming S</ForeName>
<Initials>MS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Turrisi</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vansteenkiste</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Watanabe</LastName>
<ForeName>Hirokazu</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Yi-Long</ForeName>
<Initials>YL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Baas</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Erasmus</LastName>
<ForeName>Jeremy</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hasegawa</LastName>
<ForeName>Seiki</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Inai</LastName>
<ForeName>Kouki</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kernstine</LastName>
<ForeName>Kemp</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kindler</LastName>
<ForeName>Hedy</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Krug</LastName>
<ForeName>Lee</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nackaerts</LastName>
<ForeName>Kristiaan</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pass</LastName>
<ForeName>Harvey</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rice</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Falkson</LastName>
<ForeName>Conrad</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Filosso</LastName>
<ForeName>Pier Luigi</ForeName>
<Initials>PL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Giaccone</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kondo</LastName>
<ForeName>Kazuya</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lucchi</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Okumura</LastName>
<ForeName>Meinoshin</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Blackstone</LastName>
<ForeName>Eugene</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Asamura</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Batirel</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bille</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pastorino</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Call</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cangir</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cedres</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Friedberg</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Galateau-Sallé</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hasagawa</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kernstine</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kindler</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McCaughan</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nakano</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nowak</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ozturk</LastName>
<ForeName>C Atinkaya</ForeName>
<Initials>CA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pass</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de Perrot</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rea</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rice</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rintoul</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ruffini</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rusch</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Spaggiari</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Galetta</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Syrigos</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van Meerbeeck</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nafteux</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vansteenkiste</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Weder</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Optiz</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yoshimura</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>08</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>09</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>09</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27687962</ArticleId>
<ArticleId IdType="pii">S1556-0864(16)31074-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.jtho.2016.09.124</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001513 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001513 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:27687962
   |texte=   The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:27687962" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024